ARNA

Recent Articles

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must More 

3 Stocks to Watch on Wednesday: Bank of America Corp (BAC), Arena Pharmaceuticals, Inc. (ARNA) and Fogo De Chao Inc (FOGO)

Bank of America (BAC) anxiously awaits a Fed decision on Wednesday, Arena Pharmaceuticals (ARNA) rockets higher and Fogo de Chao (FOGO) carves out some gains. More 

26 Biotechnology Stocks to Sell Now

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

23 Biotechnology Stocks to Sell Now

The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

22 Biotechnology Stocks to Sell Now

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

19 Biotechnology Stocks to Sell Now

The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Stocks to Watch on Friday: Arena Pharmaceuticals, Inc. (ARNA), Micron Technology, Inc. (MU) and Tesla Motors Inc (TSLA)

Tesla (TSLA) shares fell on a self-driving accident, Arena Pharmaceuticals (ARNA) will cut more than half its workforce and Micron (MU) misses revenue estimates. More